Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML)
Clinical trial NCT05682170 · TERMINATED
Trial details
- NCT number
- NCT05682170
- Sponsor
- K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-07-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.